Tirzepatide is a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://jayrocl944621.tribunablog.com/tirzepatide-a-game-changer-for-type-2-diabetes-55132477